ODEMSA will be hosting an EMT Hybrid course beginning November 10, 2020 - April 24, 2021. See below for the course information packet which includes a link to the online application. Applications open on Monday, September 28, 2020. Questions? Contact the course instructor, Tiffany Almeida, at firstname.lastname@example.org or by calling (804) 560-3300 ext 102. ODEMSA... Continue Reading →
Beginning October 1, 2020, Terbutaline will be added to ODEMSA drug boxes. Click on the links below for Terbutaline information including education, medication reference sheet and the updated respiratory distress protocol with Terbutaline (3-11a) during COVID-19. Terbutaline Education Download Terbutaline Medication Reference Download Respiratory-Asthma/COPD with Terbutaline (Protocol 3-11a) During COVID-19Download
Beginning October 1, 2020, Ketamine will replace Fentanyl in ODEMSA drug boxes. Click on the links below for Ketamine information including education, medication reference sheet and updated pain management protocols which reflect these changes.
As the COVID-19 pandemic remains a dynamic situation, the guidelines will be amended as needed.
Please refer to the announcement flyer for an overview of information including treatment, symptoms and proper infection control to limit exposure for EMS providers.
The Old Dominion EMS Alliance is conducting a 3-question survey to collect data regarding EMS provider interest in receiving the COVID-19 vaccine, once the vaccine becomes available. No personal information is required to complete this survey. Please click on the link to be redirected to the short survey. We appreciate your assistance. Click here to... Continue Reading →
Please click the link below to open the Virginia Office of EMS - EMS Transportation to Alternate Sites White Paper.Per the Office of EMS, the white paper provides guidance for EMS regarding transportation, protocols and funding to alternate sites in order to reduce volume on facilities during COVID -19. EMS-Transport to Alternate Sites White Paper
In order to reduce aerosolization and exposure risk, please discontinue any nebulizer/BiPAP/CPAP treatment prior to entering the Emergency Department.